-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
NeuBase Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2022.
- NeuBase Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$2.81M, a 63.6% increase year-over-year.
- NeuBase Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$15.3M, a 54.2% increase year-over-year.
- NeuBase Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$33.3M, a 25.4% decline from 2021.
- NeuBase Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$26.6M, a 55.6% decline from 2020.
- NeuBase Therapeutics, Inc. annual Operating Income (Loss) for 2020 was -$17.1M, a 33.1% increase from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)